Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
APEX ADVANTAGE Clinically formulated for maximum translucency NanoFusion technology for outstanding mechanicals Available in 4 base shades, 4 tooth shades Outstanding polishability and final aesthetics STATS WORK OF FRACTURE Resistance to propagation of damage FRACTURE RESISTANCE Maximum stress intensity before crack propagation COFFEE STAINING Change in color when exposed to coffee for 28 days WEAR RATE Volume loss during 10-year wear simulation Apex Flex Strength where it counts
AstraZeneca / Daiichi Sankyo Enhertu Redefines First-Line HER2+ Metastatic Breast Cancer Care Enhertu (trastuzumab deruxtecan), an antibodydrug conjugate, became the first ADC approved for first-line treatment of HER2-positive metastatic breast cancer after delivering a marked improvement in progression-free survival versus the long-standing THP standard in the Phase III DESTINY-Breast09 trial
is used for neuropathy relief (prevention and treatment of neurological diseases caused by chemotherapy such as Cisplatin), skin whitening and reduction of pigmentation such as melasma and age spots, anti-aging, and liver detoxification support
Jan 15, 2026 After reviewing hundreds of copper peptide products and analyzing clinical research spanning three decades, one pattern emerges with striking consistency
Nausea reduction improves medication adherence
